SCHEMBL2487430

SCHEMBL2487430

CCCCC/C=C(\NC(=O)C1CC1(C)C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638946 1.00
SCHEMBL13806071 1.00
SCHEMBL2638948 1.00
SCHEMBL9747493 0.99
SCHEMBL9747510 0.99
SCHEMBL9747914 0.99
SCHEMBL9747918 0.99
SCHEMBL9747502 0.99
SCHEMBL9748212 0.99
SCHEMBL9748223 0.99

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4603157-B2 2010-12-22 JP claimed
US-6784153-B1 IDENTIFY MOLECULES THAT CAN BIND TO ORGAN OR TISSUE SPECIFIC MARKERS AND, THEREFORE, CAN HOME TO THE ORGAN OR TISSUE; MEMBRANE DIPEPTIDASE (MDP)-BINDING HOMING MOLECULE, WHICH IS A MOLECULE THAT SELECTIVELY HOMES TO LUNG ENDOTHELIUM THE BURNHAM INSTITUTE 2004-08-31 US claimed
EP-1062232-A2 MOLECULES THAT HOME TO VARIOUS SELECTED ORGANS OR TISSUES The Burnham Institute (US) 2000-12-27 EP claimed
WO-1999046284-A9 MOLECULES THAT HOME TO VARIOUS SELECTED ORGANS OR TISSUES BURNHAM INST (US) 1999-11-18 WO claimed
WO-1999046284-A2 MOLECULES THAT HOME TO VARIOUS SELECTED ORGANS OR TISSUES THE BURNHAM INSTITUTE (US) 1999-09-16 WO claimed
US-5147868-A For selectively inhibiting the metabolism of dipeptidase; useful in mixtures with bactericides MERCK & CO., INC. (US) 1992-09-15 US claimed
US-4880793-A BACTERICIDES, UNSATURATED CARBOXYLIC ACID, AMIDES MERCK & CO., INC. (US) 1989-11-14 US claimed
US-4668504-A Use of substituted propenoates to prevent nephrotoxicity of certain antibiotics MERCK & CO., INC. (US) 1987-05-26 US claimed
EP-0072014-B1 COMBINATION OF 2-SUBSTITUTED PENEMS WITH DIPEPTIDASE INHIBITORS MERCK & CO. INC. (US) 1986-12-30 EP claimed
US-4539208-A Combination of thienamycin-type antibiotics with dipeptidase inhibitors MERCK & CO., INC. (US) 1985-09-03 US claimed
EP-0028778-B1 ANTIBACTERIAL COMPOSITIONS COMPRISING A BETA-LACTAM-TYPE COMPOUND AND A 3-SUBSTITUTED PROPENOATE MERCK & CO. INC. (US) 1985-01-16 EP claimed
EP-0010573-B1 NOVEL Z-2-ACYLAMINO-3-MONOSUBSTITUTED PROPENIC ACIDS AND THEIR ESTERS AND SALTS, AND PROCESSES FOR PREPARING THEM MERCK & CO. INC. (US) 1983-10-19 EP claimed
EP-0072014-A1 Combination of 2-substituted penems with dipeptidase inhibitors MERCK & CO. INC. (US) 1983-02-16 EP claimed
EP-0007614-B1 AN ANTIBACTERIAL COMPOSITION OF THIENAMYCIN-TYPE COMPOUND AND A DIPEPTIDASE INHIBITOR MERCK & CO. INC. (US) 1983-01-26 EP claimed
EP-0028778-A1 Antibacterial compositions comprising a beta-lactam-type compound and a 3-substituted propenoate MERCK & CO. INC. (US) 1981-05-20 EP claimed
EP-0007614-A1 An antibacterial composition of thienamycin-type compound and a dipeptidase inhibitor MERCK & CO. INC. (US) 1980-02-06 EP claimed
US-20130244929-A1 BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS MERCK SHARP & DOHME CORP. 2013-09-19 US disclosed
EP-2544702-A1 BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACTAM ANTIBACTERIALS Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
EP-0007614-A1 An antibacterial composition of thienamycin-type compound and a dipeptidase inhibitor MERCK & CO. INC. (US) 1980-02-06 EP disclosed
EP-0006639-A1 Crystalline N-formimidoyl thienamycin MERCK & CO. INC. (US) 1980-01-09 EP disclosed